Skip to main content
Log in

Prospective follow-up of genital HPV infections: Survival analysis of the HPV typing data

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

A series of 532 women with genital HPV infections has been prospectively followed-up without treatment since 1981 for a mean of 50 (+/-21) months. The patients were examined at six month intervals by colposcopy, PAP smears and/or biopsy. HPV typing of all biopsies was completed using in situ, Southern blot and/or sandwich hybridization with DNA probes for types 6, 11, 16, 18, 31 and 33. Survival data analysis was applied to analyse the clinical course (i.e. spontaneous regression and progression) of the HPV lesions stratified by their HPV type, currently available for 458 women. Clinical progression was significantly related to the HPV type present in the lesions. The progression rate was 11.1% (6/54) for HPV 6 lesions, 14.3% (8/ 56) for HPV 11, 35.2% (32/91) for HPV 16,12.5% (4/32) for HPV 18,18.8% (6/32) for HPV 31,19.4% (6/31) for HPV 33 and 28.6% (4/14) for doubly infected lesions. The lowest progression rate, 6.1% (9/ 148), was found in lesions which remained constantly HPV DNA-negative. In the survival analysis the probability of progression varied significantly between the six HPV types (p=0.0005, overall). After grouping the viral types as HPV 6/11 (‘low risk’), HPV 16/18 (‘high risk’) and HPV 31/33 (‘intermediate risk’) the overall probability of progression remained significantly different (p=0.0035, overall). In clinical regression, however, the HPV type was not an equally good predictor (p=0.1952, overall). Within groups HPV 6/11, 16/18 and 31/33 the differences were even less significant (p= 0.4759, overall). In the pairwise comparison significant differences in progression occurred when HPV type 16 was compared to HPV 6, HPV 11 or HPV DNA-negative lesions. In regression similar differences existed in comparison of HPV DNA-negative to HPV 6 or HPV 18 lesions.

These data confirm the previous finding of HPV type 16 as a ‘high risk’ type in cervical infections. Types 31 and 33 belong to ‘intermediate’ category. Although, previously included in the ‘high risk’ category, type 18 did not markedly differ from the clinical course of the ‘low risk’ (HPV 6, 11) types in the study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Boshard, M. et al. (1984): A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. - EMBO J. 3: 1151–1157

    Google Scholar 

  2. Campion, M. et al. (1986): Progressive potential of mild cervical atypia: prospective cytological, colposcopic and virological study. - Lancet ii: 237–238.

    Google Scholar 

  3. Costa, S. et al. (1988): Intramuscular Beta-interferon treatment of human papillomavirus lesions in the lower female genital tract. - Cervix & 1.f.g.t. 6: 203–212.

    Google Scholar 

  4. Cox, M.F. et al. (1986): Human papillomavirus type 16 homologous DNA in normal human ectocervix. -Lancet ii: 157.

    Google Scholar 

  5. Demeter, T. et al. (1987): Detection of DNA of human papillomavirus types 6/11 and 16/18 in cell scrapings of the uterine cervix by filter in situ hybridization. Correlation with cytology, colposcopy and histology.- Eur. J. Epidemiol. 3: 404–413.

    Google Scholar 

  6. Durst, M. et al. (1983): A papilloamavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. -Proc. Natl. Acad. Sci. USA 80: 3812–3814.

    Google Scholar 

  7. Evans, A.S. et al. (1985): Spontaneous resolution of cervical warty atypia: the relevance of clinical and nuclear DNA features: a prospective study. - Br. J. Obstetr. Gyn. 92: 165–169.

    Google Scholar 

  8. Grunebaum, [itA.N. et al. (1983): Association of human papillomavirus infection with cervical intraepithelial neoplasia. - Obstet. Gynecol. 62: 448.

    Google Scholar 

  9. Kadish, A.S. et al. (1986): Human papillomavirus of different types in precancerous lesions of the uterine cervix: histologic, immunohistochemical and ultrastrucutural studies. - Hum. Pathol. 17: 384–392.

    Google Scholar 

  10. Kaplan, E.C. et al. (1958): Nonparametric estimation from incomplete observations. - J. Am. Statist. Ass. 53: 457–481.

    Google Scholar 

  11. Kataja V. et al. (1989): Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. -Eur. J. Epidemiol. In press.

  12. Koss, L. G. (1987): Citologic and histologic manifestations of human papillomavirus infection of the female genital tract and their clinical significance.- Cancer 60: 1942–1950.

    Google Scholar 

  13. Kulski, J. K. et al. (1987): DNA sequences of human papillomavirus types 11, 16 and 18 in invasive cervical carcinoma of Western Australian women. -Immunol. Cell Biol. 65: 77–84.

    Google Scholar 

  14. Lee, E. T. (1984): Statistical methods for survival data analysis. Life Time Learning Publications, Belmont, California, pp. 9–156.

    Google Scholar 

  15. Macnab, J. C. M. et al.(1986): Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. - New Engl. J. Med. 315: 1052.

    Google Scholar 

  16. Meanwell, C.A. (1987): HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behavior of cervical neoplasia. - Lancet i: 703.

    Google Scholar 

  17. Mitchell, H. et al. (1986): Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection. - Lancet i: 573–575.

    Google Scholar 

  18. Munoz, N., Bosch, X. and Kaldor, J.M. (1988): Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. - Br. J. Cancer 57: 1–5.

    Google Scholar 

  19. Nasiell, K. et al. (1986): Behavior of mild cervical dysplasia during long term follow-up. Obstet. & Gynecol. 67: 665–669.

    Google Scholar 

  20. Okagaki, T. (1984): Female genital tumors associated with human papillomavirus infection and the concept of genital neoplasm-papilloma syndrome (GENPS). Pathol. Annu. 19: 31.

    Google Scholar 

  21. Peto, R. et al. (1977): Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and examples. - Br. J. Cancer 35: 1–39.

    Google Scholar 

  22. Reeves, W.C. et al. (1987): Case-control study of human papillomaviruses and cervical cancer in Latin America. - Int. J. Cancer 40: 450.

    Google Scholar 

  23. Robertson, J.H. et al. (1988): Risk of cervical cancer associated with mild dyskaryosis. - BMJ 297: 18–21.

    Google Scholar 

  24. Schneider, A. et al. (1987): Human papillomavirus in women with a history of abnormal papanicolaou smears and in their male partners. - Obstet. Gynecol. 69: 554.

    Google Scholar 

  25. SPSS-X Users Guide (1983): McGraw-Hill Book Company, New York, 1983, pp. 96–104.

  26. Syrjanen, K.J. (1983): Human papillomavirus (HPV) lesions in association with cervical dysplasia and neoplasms. - Obstet Gynecol. 62: 617–624.

    Google Scholar 

  27. Syrjanen, K. et al. (1985): Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix. -Eur. J. Epidemiol. 1: 180–187.

    Google Scholar 

  28. Syrjänen, K. et al. (1985): Natural history of HPV infections in uterine cervix as determined by prospective follow-up. In: P.M. Howley and T.R. Broker (eds) Papilloma viruses: Molecular and clinical aspects, UCLA Symposia on Molecular and Cellular Biology, Alan R. Liss, Inc., New York. - New Series 32: 31–45.

    Google Scholar 

  29. Syrjänen, K. et al. (1985): Cervical papillomavirus infections progressing to invasive cancer in less than three years. - Lancet i:510–511.

    Google Scholar 

  30. Syrjänen, K. et al. (1987): Assessing the biological potential of human papillomavirus infections in cervical carcinogenesis. - Cancer Cells 5 281–289.

    Google Scholar 

  31. Syrjänen, K.J.(1987):Biology of human papillomavirus (HPV) infections and their role in squamous cell carcinogenesis. - Med. Biol. 65:21–39.

    Google Scholar 

  32. Syrjänen, K. et al. (1988): Factors associated with progression of cervical Human papillomavirus (HPV) infections during a long-term prospective follow-up. Brit. J. Obstet. Gynaecol. 95: 1096–1102.

    Google Scholar 

  33. Syrjänen K. et al. (1988): Prevalence, incidence and estimated life-time risk of cervical human papillomavirus (HPV) infections in nonselected Finnish female population. — Sex. Transm. Dis. Submitted.

  34. Syrjanen, S., Syrjanen, K. (1986): An improved in situ DNA hybridization protocol for detection of human papillomavirus (HPV) DNA sequences in paraffin-embedded biopsies. - J. Virol. Methods 14: 293–304.

    Google Scholar 

  35. Syrjanen, S. et al. (1988): Sensitivity of in situ hydridization techniques using biotin- and 35-Slabelled human papillomavirus (HPV) DNA probes. -J. Virol. Methods 19: 225–228.

    Google Scholar 

  36. Väyrynen, M. (1986): Natural history of cervical HPV infections. Colposcopic assessment and biological considerations. Publications of the University of Kuopio, Orig. Rep. 2: 1–83.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Corresponding author.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kataja, V., Syrjänen, K., Syrjanen, S. et al. Prospective follow-up of genital HPV infections: Survival analysis of the HPV typing data. Eur J Epidemiol 6, 9–14 (1990). https://doi.org/10.1007/BF00155542

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00155542

Key words

Navigation